Journal
JOURNAL OF NUTRITIONAL BIOCHEMISTRY
Volume 23, Issue 4, Pages 313-319Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.jnutbio.2011.11.001
Keywords
Chromium; Insulin resistance; Type 2 diabetes
Funding
- ADA [AMDIAB47595]
- Wyoming INBRE [P20RR016474]
- Wyoming NASA Space Grant Consortium
Ask authors/readers for more resources
Type 2 diabetes is often associated with obesity, dyslipidemia and cardiovascular anomalies and is a major health problem approaching global epidemic proportions. Insulin resistance, a prediabetic condition, precedes the onset of frank type 2 diabetes and offers potential avenues for early intervention to treat the disease. Although lifestyle modifications and exercise can reduce the incidence of diabetes, compliance has proved to be difficult, warranting pharmacological interventions. However, most of the currently available drugs that improve insulin sensitivity have adverse effects. Therefore, attractive strategies to alleviate insulin resistance include dietary supplements. One such supplement is chromium, which has been shown to reduce insulin resistance in some, but not all, studies. Furthermore, the molecular mechanisms of chromium in alleviating insulin resistance remain elusive. This review examines emerging reports on the effect of chromium, as well as molecular and cellular mechanisms by which chromium may provide beneficial effects in alleviating insulin resistance. 2012 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available